Palatin Technologies PTN
NASDAQ PTN
$12.02 -0.31 (-2.51%)
At close: Sep 10, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Capital Expenditures (2012 - 2026)

Palatin Technologies' (PTN) quarterly Capital Expenditures came in at $38483.0 in Q1 2026, up 683.61% quarter-over-quarter from $4911.0 in Q2 2024.

Analysis

Palatin Technologies (PTN) Capital Expenditures (2012 - 2026) Analysis & Trends

Palatin Technologies (PTN) has reported Capital Expenditures for 11 consecutive years, with $38483.0 the latest figure, recorded in Q1 2026.

  • For the quarter ending Q1 2026, Capital Expenditures changed N/A year-over-year to $38483.0; the trailing twelve-month figure through Mar 2026 stood at $43394.0 (up 2.04% YoY), and the FY2024 full-year result was $42526.0, down 90.2% from the prior year.
  • Capital Expenditures grew to $38483.0 in Q1 2026 per PTN's latest filing, from $4911.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $141228.0 in Q3 2022 and bottomed at $4911.0 in Q2 2024.
  • Historically, Capital Expenditures has averaged $69938.7 across 4 years, with a median of $52396.0 in 2023.
  • The sharpest annual moves came in 2022 and 2024: Capital Expenditures jumped 3711500.0% in 2022, then slumped 90.63% in 2024.
  • Over 4 years, Capital Expenditures stood at $123428.0 in 2022, then sank by 69.52% to $37615.0 in 2023, then slumped by 86.94% to $4911.0 in 2024, then jumped by 683.61% to $38483.0 in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods registered $38483.0, $4911.0, and $37615.0 for Q1 2026, Q2 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 513.00 Mn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 140.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 112.20 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 240.20 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 37.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 34.68 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 40.90 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -1.87 Mn
10 Palatin Technologies 46.98 Mn 46.98 Mn - 38,483.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 38,483.00
Jun 30, 2024 4,911.00
Dec 31, 2023 37,615.00
Jun 30, 2023 52,396.00
Mar 31, 2023 116,875.00
Dec 31, 2022 123,428.00
Sep 30, 2022 141,228.00
Jun 30, 2022 37,116.00
Mar 31, 2022 77,396.00
Dec 31, 2021 89,098.00
Sep 30, 2021 57,764.00
Jun 30, 2021 1.00
Mar 31, 2021 5,721.00
Sep 30, 2019 62,880.00
Mar 31, 2019 36,139.00
Jun 30, 2018 12,951.00
Sep 30, 2017 9,500.00
Jun 30, 2017 133,403.00
Sep 30, 2015 17,695.00
Sep 30, 2013 6,239.00